Amiodarone is a class III antiarrhythmic agent that causes inhibition of outward potassium channels. This drug also has class I sodium channel blocking effects, class II antiadrenergic effects, and class IV calcium channel blocking effects. It is widely prescribed due to its efficacy in the management of ventricular and supraventricular
antiadrenergic effects, and class IV calcium channel blocking effects. It is widely prescribed due to its efficacy in the management of ventricular and supraventricular arrhythmia [1] .
Although prolonged use of amiodarone may cause numerous side effects (in the thyroid gland, liver, lungs, eyes and skin), hypersensitivity reactions to amiodarone are rare.
Moreover, there are few cases reported with a thorough allergy work-up (anaphylaxis confirmed by mast cell tryptase levels and skin testing [2] , angioedema with positive oral challenge [3, 4] , amiodarone-induced hypersensitivity pneumonitis with positive skin and basophil degranulation tests [5] ).
We report herein the first two cases of immediate amiodarone hypersensitivity with positive basophil activation test (BAT), one of them with an anaphylactic reaction.
A 48-year-old male patient was referred to our allergy department after suffering an anaphylactic reaction in the operating theater. An immediate decreased blood pressure to 60/40 mm Hg, desaturation (<90%) and rash all over the body, had appeared after an intravenous injection of amiodarone 50mg used to treat an atrial fibrillation. The patient had also received treatment with etomidate, fentanyl and rocuronium as anesthesia induction for cholecystectomy. In an attempt to clarify the underlying mechanism and the culprit agent, BAT with etomidate (1-100 µg/mL), fentanyl (1-100 µg/mL), rocuronium (5-500 µg/mL) and amiodarone was performed before skin tests for safety reasons due to the severity of the initial reaction.
BAT methodology is detailed elsewhere [6, 7, 8] . Briefly, 100µL of heparinized blood We present the first two cases of immediate hypersensitivity to amiodarone with a positive BAT.
Hypersensitivity reactions to drugs account for 15% of all adverse drug reactions [10] and represent an important health problem with significant morbidity and mortality. In the diagnosis of drug hypersensitivity, the measurement of specific IgE in vitro is available only for a limited number of drugs (as binding the molecules or their metabolites into a solid phase is often not possible), which generally display low sensitivity and are thus well complemented by BAT. Although rare, systemic reactions with skin tests have been described. 
